Spots Global Cancer Trial Database for vibostolimab
Every month we try and update this database with for vibostolimab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refractory Melanoma (MK-3475-02A/KEYMAKER-U02) | NCT04305041 | Melanoma | Pembrolizumab Quavonlimab Vibostolimab Lenvatinib ATRA | 18 Years - 120 Years | Merck Sharp & Dohme LLC | |
KEYMAKER-U01 Substudy 1: Efficacy and Safety Study of Pembrolizumab (MK-3475) Plus Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Advanced Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A) | NCT04165070 | Carcinoma, Non-... | Pembrolizumab Carboplatin Paclitaxel Pemetrexed Vibostolimab Boserolimab MK-4830 MK-0482 | 18 Years - | Merck Sharp & Dohme LLC |